Home
Loading

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

Get in touch

  • Contact

  • Request a demo

  • Request data updates

  • Add a company

Research

  • Companies

  • Investors

  • People

aVenture

  • Sitemap

  • Feature requests

Member

Backed by

© aVenture Investment Company, 2026. All rights reserved.

San Francisco, CA, USA

Privacy Policy

aVenture Investment Company ("aVenture") is an independent research platform providing detailed analysis and data on startups, venture capital investments, and key industry individuals. It is not a registered investment adviser, broker-dealer, or investment advisor and does not provide investment advice or recommendations. The data provided by aVenture does not constitute recommendations or advice, whether by methodology, analysis, AI-generated content, or a statement written by a staff member of aVenture.

aVenture is not affiliated with any of the people, companies, organizations, government agencies, regulatory bodies, or investment funds we provide coverage for on this site unless explicitly stated otherwise. Users assume full responsibility for decisions made based on information obtained from this platform. Links to external websites do not imply endorsement or affiliation with aVenture. Any links that provide the ability to invest in a primary or secondary transaction in a company are for convenience only and do not constitute solicitations or offers to buy or sell an investment. Investors should exercise heightened precaution and due diligence when investing in private companies, especially those not independently audited.

While we strive to provide valuable insights with objectivity and professional diligence, we cannot guarantee the accuracy of the information provided on our platform. Before making any investment decisions, you should verify the accuracy of all pertinent details for your decision. To the fullest extent permitted by law, aVenture shall not be liable for any direct, indirect, incidental, consequential, or financial damages arising from use of this site, whether by consumers of its contents directly or by persons or organizations covered by our research, even if we are advised of the possibility. Our best-efforts processes and correction request forms do not create a warranty or duty of care.

Profiles on this platform may include content generated in part by large language models (LLMs, artificial intelligence) that aggregate publicly available sources (e.g., SEC EDGAR, public filings, press releases). Source attribution is provided where known; always verify statements and claims here against original sources before relying on any data. Content on our site may contain inaccuracies, omissions, or what are commonly called 'hallucinations' if generated in part or in full by AI / LLMs. The risk can also exist even when content is written by a human, as internal and third-party sources may also have inaccuracies for the same or different reasons. While we randomly audit a proportion of content, this is not exhaustive.

We recommend that an independent auditor be hired to verify the accuracy of the information before relying on it for any sensitive decisions. By accessing this platform, you agree not to rely solely on any information generated by AI, aggregated, or sourced or written otherwise on this site, for investment, financial, or other decisions. aVenture assumes no responsibility for inaccuracies, omissions, or hallucinations. You must independently verify all data from primary sources. Use of this platform constitutes your waiver of claims for reliance-based damages, including negligent misrepresentation. To report an error, request a correction, or dispute information about a company or individual, contact us via our request data updates form.

Loading homepage
Loading
Home›Research›Companies

Companies

Loading
Home›
Research›
Companies›
Micardia
AddedFeb 15, 2024
UpdatedJun 24, 2026
Micardia

Micardia

Closed

MiCardia Corporation: Innovating heart valve solutions for surgical treatments.

HQ
Irvine, CA, US
Founded
2004
Overview
Compare
Fundraising
Employees

MiCardia Corporation focuses on innovating heart valve solutions for surgical treatments. The company designs, develops, and markets advanced heart valve devices aimed at treating heart valve diseases during and after surgery. MiCardia's core mission is to enhance patient outcomes through cutting-edge medical technology, addressing a critical need in the cardiovascular healthcare market.

MiCardia has made significant strides in the medical device industry by providing reliable and effective heart valve solutions. Their products have contributed to improved surgical outcomes and patient recovery rates, establishing the company as a key player in the field of cardiovascular treatment.

Micardia - Similar Companies

Cardiac Dimensions logo

Cardiac Dimensions

Viacor logo

Viacor

MicroPort CardioFlow logo

MicroPort CardioFlow

Phoenix Cardiac logo

Phoenix Cardiac

MitraSpan logo

MitraSpan

Miami Instruments logo

Miami Instruments

Innovative Cardiovascular Solutions logo

Innovative Cardiovascular Solutions

MyoCardioCare logo

MyoCardioCare

myocardiocare.com

Micron Solutions logo

Micron Solutions

Scion Cardio-Vascular logo

Scion Cardio-Vascular

MicroMed Technology logo

MicroMed Technology

micromedtech.com

Edwards Lifesciences logo

Edwards Lifesciences

edwards.com

Micro Interventional Devices logo

Micro Interventional Devices

CardioOptics logo

CardioOptics

Colibri Heart Valve logo

Colibri Heart Valve

colibrihv.com

Micardia - Quick Facts

Who are Micardia's competitors?

Companies similar to Micardia include Cardiac Dimensions, Viacor, MicroPort CardioFlow and Phoenix Cardiac.

When was Micardia founded?

Micardia was founded in 2004.

Where is Micardia's headquarters located?

Micardia's headquarters is located in Irvine, CA, US.

When was Micardia's last funding round?

Micardia's most recent funding round was for $3.7M (USD) in April 2012.

How much has Micardia raised to-date?

As of Apr 5, 2012, Micardia has raised a total of $28.9M (USD).

Micardia - Classification

Ownership
  • Private
Technology
  • HealthTech
Customer
  • Enterprise
Main Product
  • Medical Devices
Tags
  • Hardware
  • Healthcare
  • Software
NAICS
  • 320000Manufacturing
  • 325400Pharmaceutical and Medicine Manufacturing
  • 325000Chemical Manufacturing
  • 325410Pharmaceutical and Medicine Manufacturing
SIC
  • 5000Wholesale Trade-durable Goods
  • 5040Professional And Commercial Equipment And Supplies
  • 5047Medical, Dental, And Hospital Equipment And Supplies
ISIC
  • 7210Research and experimental development on natural sciences and engineering
Show 15 more industry codes
NAICS
  • 540000Professional, Scientific, and Technical Services
  • 330000Manufacturing
  • 620000Health Care and Social Assistance
  • 541000Professional, Scientific, and Technical Services
  • 623000Nursing and Residential Care Facilities
  • 541700Scientific Research and Development Services
  • 541710Research and Development in the Physical, Engineering, and Life Sciences
  • 541715Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology)
SIC
  • 3900Miscellaneous Manufacturing Industries
  • 8000Health Services
  • 8700Engineering, Accounting, Research, Management, And Related Services
  • 8040Offices And Clinics Of Other Health Practitioners
  • 8730Research, Development, And Testing Services
  • 8049Offices And Clinics Of Health Practitioners, Not Elsewhere Classified
  • 8731Commercial Physical and Biological Research